(Q51949909)

18 April 2018

title

Levodopa and executive performance in Parkinson's disease: a randomized study. (English)

1 reference

18 April 2018

1 reference

1 reference

6

1 reference

18 April 2018

Ignasi Gich

8

1 reference

18 April 2018

Antonia Campolongo

object named as

Antonia Campolongo

5

0 references

Jaime Kulisevsky

2

object named as

Jaime Kulisevsky

1 reference

18 April 2018

1

Berta Pascual-Sedano

1 reference

18 April 2018

7

Javier Pagonabarraga

1 reference

18 April 2018

Manel Barbanoj

3

1 reference

18 April 2018

Carmen García-Sánchez

4

1 reference

18 April 2018

publication date

1 September 2008

1 reference

18 April 2018

Journal of the International Neuropsychological Society

published in

1 reference

18 April 2018

volume

14

1 reference

18 April 2018

issue

5

1 reference

18 April 2018

page(s)

832-841

1 reference

18 April 2018

Dopamine supports sentence comprehension in Parkinson's Disease

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

L-dopa impairs learning, but spares generalization, in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

Subthalamic nucleus stimulation affects striato-anterior cingulate cortex circuit in a response conflict task: a PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

What contributes to quality of life in patients with Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

By carrot or by stick: cognitive reinforcement learning in parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

High-speed memory scanning in Parkinson's disease: adverse effects of levodopa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

Levodopa in the treatment of Parkinson's disease: current controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

Gene transfer of constitutively active protein kinase C into striatal neurons accelerates onset of levodopa-induced motor response alterations in parkinsonian rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

The response to levodopa in Parkinson's disease: imposing pharmacological law and order

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

What causes mental dysfunction in Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

Continuous dopaminergic stimulation: Is it the answer to the motor complications of Levodopa?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

Pathogenesis of dyskinesias in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

Insights into the role of dopamine receptor systems in learning and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

The neural correlates and functional integration of cognitive control in a Stroop task.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

Neural bases of set-shifting deficits in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

A model of prefrontal cortex dopaminergic modulation during the delayed alternation task

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

Dissociable effects of dopaminergic therapy on spatial versus non-spatial working memory in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

Issues associated with repeated neuropsychological assessments

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

The role of the striatum and hippocampus in planning: a PET activation study in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

Dopaminergic modulation of cortical function in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

Molecular imaging of the dopaminergic system and its association with human cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

Coupled temporal memories in Parkinson's disease: a dopamine-related dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

Dopaminergic modulation of visual-spatial working memory in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

Impaired simultaneous cognitive task performance in Parkinson's disease: a dopamine-related dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

Cognitive deficits in the early stages of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson's disease patients at different levodopa plasma levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

Modulation of memory fields by dopamine D1 receptors in prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

Cognitive function in Parkinson's disease: From description to theory

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

Persistent changes in striatal gene expression induced by long-term L-DOPA treatment in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

Neuropsychological profile of patients with Parkinson's disease without dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

High-Speed Scanning in Human Memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

Basal ganglia dysfunction, working memory, and sentence comprehension in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

Detection of mild cognitive deficits in Parkinson's disease patients with the WAIS-R NI.

21 January 2018

2 references

https://api.crossref.org/works/10.1017%2FS1355617708081010

21 January 2018

https://api.crossref.org/works/10.1017%2FS1355617708081010

7 January 2021

Shared cognitive processes underlying performance on the Wisconsin Card Sorting Test and the Stroop Test in patients with schizophrenia: a measurement artifact?

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

7 January 2021

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

7 January 2021

D(1) receptors in prefrontal cells and circuits

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

7 January 2021

Clinical applications of visual analogue scales: a critical review.

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

7 January 2021

Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

7 January 2021

Chronic stress induces impairment of spatial working memory because of prefrontal dopaminergic dysfunction.

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

7 January 2021

Nonmotor fluctuations in Parkinson's disease: frequent and disabling

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

7 January 2021

Working memory functioning in medicated Parkinson's disease patients and the effect of withdrawal of dopaminergic medication.

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708081010

7 January 2021

10.1017/S1355617708081010

Identifiers

DOI

1 reference

18 April 2018

1 reference

18 April 2018